{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:57:33Z","timestamp":1792396653256,"version":"4.4.0"},"reference-count":41,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2020,3,8]],"date-time":"2020-03-08T00:00:00Z","timestamp":1583625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science Center","award":["2015\/19\/B\/NZ2\/02453"],"award-info":[{"award-number":["2015\/19\/B\/NZ2\/02453"]}]},{"name":"National Science Center PL","award":["2015\/18\/E\/NZ2\/00678; 2018\/29\/B\/NZ1\/00293; 2015\/17\/D\/NZ5\/03443, 2015\/17\/N\/NZ2\/01916"],"award-info":[{"award-number":["2015\/18\/E\/NZ2\/00678; 2018\/29\/B\/NZ1\/00293; 2015\/17\/D\/NZ5\/03443, 2015\/17\/N\/NZ2\/01916"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Huntington\u2019s disease (HD) is a fatal neurodegenerative disorder caused by the expansion of CAG repeats in exon 1 of the huntingtin gene (HTT). Despite its monogenic nature, HD pathogenesis is still not fully understood, and no effective therapy is available to patients. The development of new techniques such as genome engineering has generated new opportunities in the field of disease modeling and enabled the generation of isogenic models with the same genetic background. These models are very valuable for studying the pathogenesis of a disease and for drug screening. Here, we report the generation of a series of homozygous HEK 293T cell lines with different numbers of CAG repeats at the HTT locus and demonstrate their usefulness for testing therapeutic reagents. In addition, using the CRISPR-Cas9 system, we corrected the mutation in HD human induced pluripotent stem cells and generated a knock-out of the HTT gene, thus providing a comprehensive set of isogenic cell lines for HD investigation.<\/jats:p>","DOI":"10.3390\/ijms21051854","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T05:37:34Z","timestamp":1583732254000},"page":"1854","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Generation of New Isogenic Models of Huntington\u2019s Disease Using CRISPR-Cas9 Technology"],"prefix":"10.3390","volume":"21","author":[{"given":"Magdalena","family":"Dabrowska","sequence":"first","affiliation":[{"name":"Department of Genome Engineering, Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12\/14, 61-704 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2586-0907","authenticated-orcid":false,"given":"Agata","family":"Ciolak","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12\/14, 61-704 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4742-5001","authenticated-orcid":false,"given":"Emilia","family":"Kozlowska","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12\/14, 61-704 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7829-1926","authenticated-orcid":false,"given":"Agnieszka","family":"Fiszer","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12\/14, 61-704 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8471-6302","authenticated-orcid":false,"given":"Marta","family":"Olejniczak","sequence":"additional","affiliation":[{"name":"Department of Genome Engineering, Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12\/14, 61-704 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,3,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group","volume":"72","author":"Macdonald","year":"1993","journal-title":"Cell"},{"key":"ref_2","first-page":"16","article-title":"Phenotypic characterization of individuals with 30\u201340 CAG repeats in the huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36\u201339 repeats","volume":"59","author":"Rubinsztein","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199405193302001","article-title":"A worldwide study of the huntington\u2019s disease mutation: The sensitivity and specificity of measuring CAG repeats","volume":"330","author":"Kremer","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0092-8674(00)80514-0","article-title":"Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo","volume":"90","author":"Scherzinger","year":"1997","journal-title":"Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0896-6273(02)00872-3","article-title":"Polyglutamine pathogenesis: Emergence of unifying mechanisms for Huntington\u2019s disease and related disorders","volume":"35","author":"Ross","year":"2002","journal-title":"Neuron"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.brainres.2015.09.020","article-title":"IPSC-based drug screening for Huntington\u2019s disease","volume":"1638","author":"Zhang","year":"2015","journal-title":"Brain Res."},{"key":"ref_8","unstructured":"Consortium GM of HD, Lee, J.-M., Correia, K., Loupe, J., Kim, K.-H., Barker, D., Hong, E., Chao, M., Long, J., and Lucente, D. (2019). Huntington\u2019s disease onset is determined by length of uninterrupted CAG, not encoded polyglutamine, and is modified by DNA maintenance mechanisms. bioRxiv."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1474-4422(17)30280-6","article-title":"Therapies targeting DNA and RNA in Huntington\u2019s disease","volume":"16","author":"Wild","year":"2017","journal-title":"Lancet Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.neuron.2019.01.039","article-title":"Huntingtin Lowering Strategies for Disease Modification in Huntington\u2019s Disease","volume":"101","author":"Tabrizi","year":"2019","journal-title":"Neuron"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/B978-0-12-801185-0.00006-4","article-title":"Genome Editing in Human Stem Cells","volume":"546","author":"Byrne","year":"2014","journal-title":"Methods Enzymol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"8275","DOI":"10.1093\/nar\/gky548","article-title":"Efficient CRISPR\/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells","volume":"46","author":"Dastidar","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.celrep.2015.08.084","article-title":"Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons","volume":"13","author":"Park","year":"2015","journal-title":"Cell Rep."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Raaijmakers, R.H.L., Ripken, L., Ausems, R., and Wansink, D.G. (2019). CRISPR\/Cas Applications in Myotonic Dystrophy: Expanding Opportunities. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20153689"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.scr.2015.12.048","article-title":"Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H266","volume":"16","author":"Marthaler","year":"2016","journal-title":"Stem Cell Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"180177","DOI":"10.1098\/rsob.180177","article-title":"Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease","volume":"9","author":"Wu","year":"2019","journal-title":"Open Boil."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1007\/s00018-016-2284-0","article-title":"Modeling simple repeat expansion diseases with iPSC technology","volume":"73","author":"Jaworska","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.stem.2012.04.026","article-title":"Genetic correction of Huntington\u2019s disease phenotypes in induced pluripotent stem cells","volume":"11","author":"An","year":"2012","journal-title":"Cell Stem Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.stemcr.2017.01.022","article-title":"Reversal of Phenotypic Abnormalities by CRISPR\/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells","volume":"8","author":"Xu","year":"2017","journal-title":"Stem Cell Rep."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"An, M.C., O\u2019Brien, R.N., Zhang, N., Patra, B.N., De La Cruz, M., Ray, A., and Ellerby, L.M. (2014). Polyglutamine Disease Modeling: Epitope Based Screen for Homologous Recombination using CRISPR\/Cas9 System. PLoS Curr., 6.","DOI":"10.1371\/currents.hd.0242d2e7ad72225efa72f6964589369a"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1016\/j.celrep.2019.02.008","article-title":"Unbiased Profiling of Isogenic Huntington Disease hPSC-Derived CNS and Peripheral Cells Reveals Strong Cell-Type Specificity of CAG Length Effects","volume":"26","author":"Ooi","year":"2019","journal-title":"Cell Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbagrm.2015.11.005","article-title":"Sequence-non-specific effects generated by various types of RNA interference triggers","volume":"1859","author":"Olejniczak","year":"2016","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Morozova, K., Suldina, L.A., Malankhanova, T.B., Grigor\u2019Eva, E.V., Zakian, S.M., Kiseleva, E., and Malakhova, A.A. (2018). Introducing an expanded CAG tract into the huntingtin gene causes a wide spectrum of ultrastructural defects in cultured human cells. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0204735"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"D\u0105browska, M., Juzwa, W., Krzyzosiak, W.J., and Olejniczak, M. (2018). Precise Excision of the CAG Tract from the Huntingtin Gene by Cas9 Nickases. Front. Mol. Neurosci., 12.","DOI":"10.3389\/fnins.2018.00075"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neures.2005.06.021","article-title":"Clinico-pathological rescue of a model mouse of Huntington\u2019s disease by siRNA","volume":"53","author":"Wang","year":"2005","journal-title":"Neurosci. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"10426","DOI":"10.1093\/nar\/gkt825","article-title":"Self-duplexing CUG repeats selectively inhibit mutant huntingtin expression","volume":"41","author":"Fiszer","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The Biology of Huntingtin","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1038\/s41467-018-06281-3","article-title":"Regulatory mechanisms of incomplete huntingtin mRNA splicing","volume":"9","author":"Neueder","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1073\/pnas.1221891110","article-title":"Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease","volume":"110","author":"Sathasivam","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1093\/nar\/gky505","article-title":"qEva-CRISPR: A method for quantitative evaluation of CRISPR\/Cas-mediated genome editing in target and off-target sites","volume":"46","author":"Czubak","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.gene.2015.05.065","article-title":"HEK293 in cell biology and cancer research: Phenotype, karyotype, tumorigenicity, and stress-induced genome-phenotype evolution","volume":"569","author":"Stepanenko","year":"2015","journal-title":"Gene"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"\u015awito\u0144ska, K., Szlachcic, W.J., Handschuh, L., Wojciechowski, P., Marczak, \u0141., Stelmaszczuk, M., Figlerowicz, M., and Figiel, M. (2019). Identification of Altered Developmental Pathways in Human Juvenile HD iPSC With 71Q and 109Q Using Transcriptome Profiling. Front. Cell. Neurosci., 12.","DOI":"10.3389\/fncel.2018.00528"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-1-4939-9784-8_17","article-title":"Gene Therapy for Huntington\u2019s Disease Using Targeted Endonucleases","volume":"2056","author":"Dabrowska","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.stemcr.2018.11.020","article-title":"Method to Synchronize Cell Cycle of Human Pluripotent Stem Cells without Affecting Their Fundamental Characteristics","volume":"12","author":"Yiangou","year":"2018","journal-title":"Stem Cell Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"21264","DOI":"10.1038\/srep21264","article-title":"Enrichment of G2\/M cell cycle phase in human pluripotent stem cells enhances HDR-mediated gene repair with customizable endonucleases","volume":"6","author":"Yang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1093\/bioinformatics\/btu376","article-title":"ABRA: Improved coding indel detection via assembly-based realignment","volume":"30","author":"Mose","year":"2014","journal-title":"Bioinformatics"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"W408-12","DOI":"10.1093\/nar\/gkv451","article-title":"CCTOP: A Consensus Constrained TOPology prediction web server","volume":"43","author":"Dobson","year":"2015","journal-title":"Nucleic Acids Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/5\/1854\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:05:16Z","timestamp":1760173516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/5\/1854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,8]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["ijms21051854"],"URL":"https:\/\/doi.org\/10.3390\/ijms21051854","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737585023.793593631","asserted-by":"object"}]},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,8]]}}}